Research.Patient.info
Locally Advanced Rectal Cancer (LARC) research hub
2 indexed studies · 2 currently recruiting
- recruitingPHASE1
NG-350A Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
This study is testing a new drug called NG-350A, given into a vein, alongside standard treatment (chemotherapy and radiotherapy) for locally advanced bowel cancer in the back passage (rectum). It aims to see how safe and effective this combination is for adults.
United States · United Kingdom - recruitingPHASE2
Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.
This study looks at adding a new drug, Tislelizumab, to standard treatment for advanced bowel cancer. It aims to see if this combination can help more people avoid surgery in the long term, by making the existing treatment even more effective.
Germany · Israel